Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study
RIO-Europe Study Group
Research output: Contribution to journal › Article › Academic › peer-review
138Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study'. Together they form a unique fingerprint.